| Financial Year |
March 31 2023 |
| Monetary Funds |
565,326,281.42 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,329,715,635.80 |
| Advances to Suppliers |
165,472,440.84 |
| Other Receivables |
58,439,745.25 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,284,111,992.30 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,494,904.11 |
| Total Current Assets |
3,828,512,742.01 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
123,539,265.95 |
| Investment Properties |
923,879.41 |
| Fixed Assetes |
724,037,574.52 |
| Under-construction Projects |
78,625,851.34 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
103,340,384.93 |
| R&D expenses |
2,544,247.87 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
6,126,300.02 |
| Deferred Income Tax Assets |
80,329,500.88 |
| Other Non-Current Assets |
47,612,120.04 |
| Sub-Total of Non-Current Assets |
1,331,309,973.48 |
| Total Assets |
5,159,822,715.49 |
| Short-Term Loans |
1,131,965,720.77 |
| Trading Financial liabilities |
-- |
| Notes Payable |
443,792,380.23 |
| Accounts Payable |
961,429,883.05 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
10,471,602.10 |
| Taxes Payable |
8,198,322.14 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
115,226,225.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
100,946,272.03 |
| Other Current Liabilities |
220,036,260.27 |
| Sub-Total of Current Liabilities |
3,138,077,929.49 |
| Long-term Loans |
250,046,330.56 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
40,863,292.47 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,050,533.22 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
458,227,155.20 |
| Total Liabilities |
3,596,305,084.69 |
| Paid-In Capital(Or Share Stock) |
441,748,000.00 |
| Capital Surplus |
907,679,575.74 |
| Surplus Reserve |
49,010,434.77 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
81,164,613.84 |
| Minority Stockholder's Interest |
14,484,211.96 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,549,033,418.84 |
| Owner's Equity（Stockholder's Equity） |
1,563,517,630.80 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
5,159,822,715.49 |
